INQUIRER.net stock photo A fertility doctor from Ottawa, Canada who used his own sperm to impregnate patients has agreed to pay millions of dollars in settlement. Dr. Norman Barwin allegedly used wrong sperm, sometimes his own, in hundreds of artificial insemination procedures. This led to the conception of 17 of his own children out of at least 100, as per CBC News last Wednesday, July 28. Complainant families will be splitting up at least CA$13 million (more than P520 million) as part of a negotiated proposed settlement after a judge certified a class-action lawsuit launched in 2016. The lawsuit has 226 members, including Barwin’s former patients and their children. “While I am aware of a few other doctors in the world who did what Dr. Barwin did, I am not aware of any other class action or settlement like this anywhere else in the world,” Peter Cronyn, the lawyer representing the families, was quoted as saying. Barwin, however, “denied and continues to deny all of the …
Realtor Groups Bring Eviction Moratorium Case To Supreme Court, Argue Against CDC’s ‘Staggering’ Power
A group of realtor organizations asked the Supreme Court to block the federal eviction moratorium that has been in effect throughout the pandemic and prevents landlords from evicting tenants who skip rent payments. The group, led by the Alabama Association of Realtors, asked the Supreme Court on Thursday to issue an emergency order blocking the moratorium, which had been crafted by the Centers for Disease Control and Prevention (CDC), according to court filings . The moratorium has resulted in more than $13 billion in unpaid rent per month since it was introduced, the coalition wrote to the high court. “Congress never gave the CDC the staggering amount of power it now claims,” the groups’ filing said. (RELATED: Nearly 20% Of American Renters Are Behind On Payments, Analysis Shows) The CDC first issued the moratorium in September in response to the large uptick in Americans entering the unemployed rolls. President Joe Biden signed an executive order on Jan. 20, his …
Should You Buy Johnson & Johnson For Its COVID Vaccine?
So far, some coronavirus vaccine stocks have offered investors enormous gains in a short period of time. For example, Moderna ( NASDAQ:MRNA ) stock climbed more than 400% last year as investors bet on its investigational vaccine. At the same time, Pfizer ( NYSE:PFE ) fell less than 1% last year -- even though the company led the vaccine race along with Moderna. In fact, Pfizer's vaccine eventually became the first to win Emergency Use Authorization (EUA). Moderna earned its EUA about a week later. Investing in either of those companies for their COVID-19 vaccines brought vastly different results. Now, let's look ahead at the next company to possibly enter the market. Johnson & Johnson 's ( NYSE:JNJ ) candidate is currently in phase 3 trials, and interim data is expected later this month. If all is positive, Johnson & Johnson might be the third to cross the vaccine race finish line. Should investors consider buying shares of the pharmaceutical giant for that …
Continue Reading about Should You Buy Johnson & Johnson For Its COVID Vaccine? →